1. Home
  2. USAS vs GHRS Comparison

USAS vs GHRS Comparison

Compare USAS & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$5.62

Market Cap

1.7B

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$28.92

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAS
GHRS
Founded
1998
2018
Country
Canada
Ireland
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
USAS
GHRS
Price
$5.62
$28.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$6.50
$41.38
AVG Volume (30 Days)
4.7M
322.1K
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$174.68
N/A
Revenue Next Year
$53.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$11.83
52 Week High
$10.50
$31.44

Technical Indicators

Market Signals
Indicator
USAS
GHRS
Relative Strength Index (RSI) 61.54 51.79
Support Level $4.88 $28.05
Resistance Level $6.24 $28.96
Average True Range (ATR) 0.24 1.44
MACD 0.06 -0.27
Stochastic Oscillator 85.25 37.19

Price Performance

Historical Comparison
USAS
GHRS

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: